AIOM· @AIOMtweet · X·· 22 小时前评分70
正文 · 机器翻译
#ESMO26：VOLGA研究结果为治疗#tumoredellavescica肌层浸润性膀胱癌开辟了新前景。
阅读文章：https://www.medinews.it/comunicati/tumore-della-vescica-muscolo-invasivo-durvalumab-perioperatorio-piu-enfortumab-vedotin-neoadiuvante-ha-ridotto-il-rischio-di-recidiva-del-49-e-il-rischio-di-morte-del-42/
@myESMO
27 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA2按 Presidential Symposium I 对上
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.org来源：AIOM · x.com